Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-binding protein (IGFBP)-2 gene expression in spleens of juvenile rats.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7528707)

Published in Horm Metab Res on August 01, 1994

Authors

S Yakar1, H Domene, R Meidan, F Cassorla, I Gilad, I Koch, Z Laron, C T Roberts, D LeRoith, R Eshet

Author Affiliations

1: Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Child and Human Development, National Institutes of Health, Bethesda, Maryland.

Articles citing this

Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates. Front Endocrinol (Lausanne) (2014) 0.77

Articles by these authors

Prediction of deleterious human alleles. Hum Mol Genet (2001) 21.00

Non-colonic features of irritable bowel syndrome. Gut (1986) 5.48

Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A (1999) 4.84

Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev (1995) 3.58

Orthodontics in the general dental service of England and Wales: a critical assessment of standards. Br Dent J (1993) 3.52

Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A (1999) 2.62

Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses (1995) 2.53

A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem (1997) 2.50

Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A (2001) 2.35

Exploring the pathway structure of metabolism: decomposition into subnetworks and application to Mycoplasma pneumoniae. Bioinformatics (2002) 2.34

Insulin-like growth factors and cancer. Ann Intern Med (1995) 2.29

The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics (2001) 2.21

RNA-RNA interaction is required for the formation of specific bicoid mRNA 3' UTR-STAUFEN ribonucleoprotein particles. EMBO J (1997) 2.13

Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med (2002) 2.13

Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Biol Chem (1997) 2.12

Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A (1996) 2.09

A cycloheximide-resistant mutant of Tetrahymena pyriformis. Exp Cell Res (1973) 2.06

Pattern of month of birth in diabetic and non-diabetic adults. Isr Med Assoc J (2002) 2.03

Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism? Isr J Med Sci (1966) 2.03

The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts. J Biol Chem (1997) 1.98

Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci U S A (1989) 1.95

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89

Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci U S A (1997) 1.88

The development of the PAR Index (Peer Assessment Rating): reliability and validity. Eur J Orthod (1992) 1.78

Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci U S A (2004) 1.75

Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology (1997) 1.68

Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med (1997) 1.67

A reference cross DNA panel for zebrafish (Danio rerio) anchored with simple sequence length polymorphisms. Development (1996) 1.67

Cortisol production rate in childhood and adolescence. J Pediatr (1990) 1.66

The PAR Index (Peer Assessment Rating): methods to determine outcome of orthodontic treatment in terms of improvement and standards. Eur J Orthod (1992) 1.63

Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem (1999) 1.60

Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci U S A (1993) 1.59

Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int J Obes (Lond) (2009) 1.59

Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci (1969) 1.54

Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem (2001) 1.54

Ectopic thyroid gland. A clinical study of 30 children and review. J Pediatr (1978) 1.53

Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol (1998) 1.52

The role of the insulin-like growth factor system in human cancer. Adv Cancer Res (1996) 1.52

Laron syndrome due to a post-receptor defect: response to IGF-I treatment. Isr J Med Sci (1993) 1.49

Oral clonidine as a growth hormone stimulation test. Lancet (1979) 1.48

Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience (1992) 1.48

Decreased insulin-like growth factor-I receptor sites on circulating mononuclear cells from children with acute leukemia. Pediatr Hematol Oncol (2000) 1.47

Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res (2001) 1.46

Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy. Isr Med Assoc J (2000) 1.46

Regulation of endothelin-1 expression in the bovine corpus luteum: elevation by prostaglandin F 2 alpha. Endocrinology (1996) 1.45

Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A (1989) 1.44

Impact of the Gulf War on the anxiety, cortisol, and growth hormone levels of Israeli civilians. Am J Psychiatry (1994) 1.44

Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal (2001) 1.43

Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab (1971) 1.43

Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. Eur J Endocrinol (1997) 1.42

Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm IGF Res (2006) 1.41

Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia (2004) 1.40

Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone. J Endocrinol Invest (1992) 1.40

True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab (1984) 1.40

Safety of pituitary growth hormone extracted with acetone/acetic acid. Lancet (1994) 1.38

Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest (1997) 1.37

Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol (1987) 1.34

Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology (1999) 1.34

Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest (1996) 1.33

Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proc Natl Acad Sci U S A (1987) 1.33

Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). J Biol Chem (1993) 1.31

The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers: implications for mammalian biology. N Engl J Med (1982) 1.31

Impaired reproduction in heat-stressed cattle: basic and applied aspects. Anim Reprod Sci (2000) 1.31

Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci (1984) 1.30

Withdrawal of human pituitary growth hormone. Lancet (1985) 1.30

Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum Reprod Update (2009) 1.29

Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol (1990) 1.29

Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J Biol Chem (1999) 1.28

Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp Biochem Physiol B Biochem Mol Biol (1998) 1.26

Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry (2007) 1.25

Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem Biophys Res Commun (1991) 1.24

Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci U S A (1997) 1.23

A unique association of short stature, dysmorphic features, and speech impairment (Floating-Harbor syndrome). J Pediatr (1988) 1.23

A multidisciplinary, comprehensive, ambulatory treatment scheme for diabetes mellitus in children. Diabetes Care (1980) 1.23

Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab (1995) 1.21

Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J Biol Chem (1997) 1.21

Insulin and IGF-1 induce different patterns of gene expression in mouse fibroblast NIH-3T3 cells: identification by cDNA microarray analysis. Endocrinology (2001) 1.20

Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system. Proc Soc Exp Biol Med (2000) 1.19

Role of the IGF-I receptor in mutagenesis and tumor promotion. J Endocrinol (1997) 1.18

Cytoplasmic inheritance of chloramphenicol resistance in tetrahymena. Genetics (1973) 1.18

Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Oncogene (2012) 1.17

The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update (2012) 1.16

Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study. BJOG (2010) 1.16

Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers. J Biol Chem (1992) 1.15

Update on diabetes mellitus: prevention, treatment, and association with oral diseases. Oral Dis (2008) 1.15

Insulin-like growth factor I receptor signaling--overlapping or redundant pathways? Endocrinology (2000) 1.15

Age at first conscious ejaculation: a milestone in male puberty. Helv Paediatr Acta (1980) 1.14

The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J Biol Chem (2000) 1.14

Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia (2011) 1.14

Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol Endocrinol (1994) 1.14